The primary clinical research programs in the Division include:

1. Secondary forms of hypertension, including new methods to diagnose and manage renovascular hypertension, adrenal hypertension, Christopher Wilcox, MD, PhD.
2. Renal disease, Francisco Llach, MD, Christopher Wilcox, MD, PhD, Jason Umans, MD, PhD, Shakil Aslam, MD.
3. Hypertension in pregnancy, Jason Umans, MD, PhD.
4. New cardiovascular risk factors and their treatment in patients with renal disease, Shakil Aslam, MD, Christopher Wilcox, MD, PhD.
5. Causes and new treatment for hyperhomocysteinemia, Christopher Wilcox, MD, PhD, Joyce Gonin, MD.
6. New therapies for metabolic bone disease, Francisco Llach, MD.